Emergent Biosolutions Inc. Receivables

Receivables of EBS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Receivables growth rates and interactive chart. Accounts receivable (AR) is the balance of money due to a firm for goods or services delivered or used but not yet paid for by customers. Accounts receivables are listed on the balance sheet as a current asset. AR is any amount of money owed by customers for purchases made on credit. When a company makes a sale, it records revenues and a corresponding balance in accounts receivable. When an invoice is paid, the accounts payable account is reduced and cash is received. Receivables should grow in-line with revenue over time, if they are growing much faster, a company might be booking revenue too aggressively.

Highlights and Quick Summary

  • Receivables for the quarter ending June 30, 2023 was $290 Million (a 86.08% increase compared to previous quarter)
  • Year-over-year quarterly Receivables increased by 51.65%
  • Annual Receivables for 2022 was $158 Million (a -42.34% decrease from previous year)
  • Annual Receivables for 2021 was $275 Million (a 18.97% increase from previous year)
  • Annual Receivables for 2020 was $231 Million (a -14.7% decrease from previous year)
Visit stockrow.com/EBS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Receivables of Emergent Biosolutions Inc.

Most recent Receivablesof EBS including historical data for past 10 years.

Interactive Chart of Receivables of Emergent Biosolutions Inc.

Emergent Biosolutions Inc. Receivables for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $290.1 $155.9 – – –
2022 $158.4 $191.3 $175.0 $181.8 $158.4
2021 $274.7 $254.6 $261.9 $184.4 $274.7
2020 $230.9 $196.1 $258.6 $172.7 $230.9
2019 $270.7 $281.2 $218.1 $121.5 $270.7
2018 $271.1 $76.96 $189.49 $129.13 $271.1
2017 $146.1 $129.36 $108.63 $134.85 $146.1
2016 $148.47 $81.46 $75.93 $73.33 $148.47
2015 $120.48 $60.47 $112.86 $81.08 $120.48
2014 $60.19 $52.37 $94.94 $80.74 $60.19
2013 $66.24 $30.68 $60.87 $73.73 $66.24
2012 $96.04 – – – $96.04

Business Profile of Emergent Biosolutions Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic
© stockrow.com